Healthtech Has a Brand Problem, and It Looks Like Every Other Healthtech

I did something recently that I recommend to anyone working in digital health. I opened ten healthtech company websites in ten separate browser tabs. Then I shuffled the tabs randomly, so I could not see the URLs. Then I tried to identify which company was which by looking only at the design.

I got two out of ten.

Blue. White. Geometric sans-serif. Generous white space. Rounded corners on every button. Photography of smiling patients and doctors, the patients visibly healthy and the doctors visibly compassionate, both clearly cast. A hero section in large type promising to "transform patient care" or "reimagine healthcare" or "empower healthier lives." A row of partner logos. A three-column feature grid. The clinical warmth of a waiting room that has been designed to feel less like a waiting room but still, inescapably, is one.

The sameness is not a failure of any individual company. Taken one at a time, each website is perfectly fine. The colors are appropriate. The typography is clean. The photography is professional. The problem only becomes visible when you see them together, when the collective effect reveals that nobody in the room is saying anything that everyone else is not also saying. The sameness is the industry's answer to a question that nobody asked aloud: what does a healthcare technology company look like? And the answer, apparently, is: blue, white, and indistinguishable from the company next door.

The anxiety driving this conformity is real. Healthcare is regulated. Healthcare is serious. Healthcare involves sick people, vulnerable people, people in pain. A founder with a clinical background carries a legitimate worry that an unusual color palette will read as frivolous. That warmth will be confused with a lack of rigor. That looking different will be interpreted, somehow, as being less safe. Blue connotes trust and reliability. White connotes clinical cleanliness. Together, they form the palette of the hospital corridor, and the hospital corridor has become the unconscious template for an entire industry's visual identity.

The reasoning is understandable. The conclusion is wrong.

Looking identical to your competition is not a safe choice. It is a concession. It says: we have nothing distinctive to offer, so we will signal our category membership instead. And the costs of that concession are specific and measurable.

Start with investors. A venture capitalist evaluating healthtech companies sees dozens of pitch decks and websites per quarter. When every company in the pipeline uses the same visual language, the investor's pattern-recognition system sorts them into a single undifferentiated category. The company becomes its sector rather than itself. The investor remembers "that healthtech thing with the blue logo" rather than the company's name, its founders, or its specific value. This sorting effect is not a vague aesthetic concern. It shows up in whether the deck gets a second reading, whether the email gets a reply, whether the company sticks in the investor's mind at ten in the evening when they are deciding which of eight similar opportunities to pursue.

Move to patients. When every telehealth platform looks the same, users have no visual basis for choosing between them. They default to price, to a friend's recommendation, to whichever app appeared first in the App Store search. This is commodity competition. A company whose identity communicates nothing specific about its values or approach is asking users to treat its product as interchangeable. Interchangeable products compete on price. Startups with real operational costs cannot win a price war.

Move to talent. A product designer or engineer evaluating job offers will look at the company's website and form an impression about whether this is a place that values good work. The blue-white monoculture sends a specific message to design-literate people: visual quality is not a priority here. This perception makes it harder for healthtech companies to hire the kind of creative talent that could, if given the chance, build the genuinely differentiated experiences that patients deserve.

The assumption that looking different means looking unserious has been disproven enough times that it should not need further evidence, but here is some anyway. Oscar Health built its identity around bold illustration and a warm color palette that had nothing in common with clinical aesthetics. The design was a strategic decision rooted in a specific insight: Oscar's customers were ordinary people shopping for insurance, a task most of them found confusing and alienating. The brand's warmth lowered the emotional barrier to engagement. Oscar went public. The playful identity did not prevent it.

Headspace wrapped mental health support in soft, rounded illustration and an orange palette that a hospital designer would never approve. The brand made a philosophical statement: wellness is not a clinical experience. It is a human one. Headspace became one of the most recognized brands in mental health precisely because it looked nothing like mental health was supposed to look.

Hims upended telehealth aesthetics entirely, borrowing design language from direct-to-consumer lifestyle brands rather than medical institutions. Warm photography. Millennial color palettes. Copy that sounded like a friend rather than a physician. The company reached a valuation above $1 billion. Patients did not question its medical credibility because of its brand. They engaged with it because the brand made healthcare feel like something designed for them, rather than something they were being processed through.

The most interesting companies in this space are going further still, refusing the healthtech label altogether. Moccet, which calls itself personal intelligence, built a brand around an idea that most health companies have not arrived at yet: that the system should know you well enough to act on your behalf, quietly, in the background, without requiring you to perform the labor of managing your own wellbeing. The identity reflects that ambition. It does not look like a health app. It does not look like a dashboard. It looks like something that has not existed before, which is appropriate, because nothing quite like it has.

Each of these companies took a risk. Each also answered a question that most healthtech companies never ask: what visual language would make the specific people we serve feel most understood?

This question, simple as it sounds, is the one the blue-white monoculture avoids. It substitutes category convention for audience insight. It asks "what does a healthtech company look like?" when it should be asking "what would make a forty-year-old mother with diabetes feel that this app was built with her in mind?" or "what would make a teenager with anxiety feel that this platform understands their world?" The answers to those questions will not be blue and white. They will be specific, human, and different from each other, because the people they serve are specific, human, and different from each other.

A telehealth platform for elderly patients might build its identity around legibility, warmth, and the colors of a living room rather than an examination room. A pediatric health app might adopt the visual vocabulary of children's media, because its users are children, and children do not respond to institutional minimalism. A fertility technology company might use rich, organic imagery drawn from the natural world. A mental health app for college students might look like the platforms those students already live on, TikTok's informality and Instagram's visual sophistication, rather than the clinical register of a journal they will never read.

Each of these directions requires courage. Each also requires something the blue-white monoculture does not: genuine thought about who the company serves and what those people need to feel in order to trust it.

The sameness of healthtech branding is not, in the end, a design problem. It is a thinking problem. The companies that look identical do so because they have not done the harder work of asking what their brand should actually mean. They have asked what it should look like, which is a much easier question and a much less useful one, because the answer to "what should it look like" depends entirely on the answer to "what do we believe, who are we for, and how do we want them to feel when they find us."

The waiting room is full of identical chairs. The patients are sitting in them, scrolling through identical apps, wondering why none of them seem to have been designed by someone who knows what it feels like to be sick and scared and looking for help.

The company that answers that feeling will not be blue and white. It will be something nobody has seen yet. And it will be unmistakable.